Shenzhen, [September 29] C&O today announces the launch of its first next-generation proton pump inhibitor, Rabeprazole Sodium for Injection (Aobo Ping?), in China. Aubergine? is a self-developed product of C&O.
MoreRabeprazole Sodium for Injection (Aobo Ping?) has been approved for drug registration and will be launched soon!
MoreContact telephone numbers for Rabeprazole Sodium for Injection (Aobo Ping) in provinces
MoreRabeprazole Sodium for Injection (Aobo Ping?) agent registration form
More
Address5/F, Jihao Building, 1086 Shennan East Road, Luohu District, Shenzhen
Adverse drug reactions / Event feedback hotline025-6816 1304
Adverse drug reactions / Event feedback mailGVP@changao.com
Official WeChat account 
Mobile page